*An eight week treatment with psyllium lowered serum total cholesterol levels by 14.8% and low-density lipoprotein cholesterol by 20.2%.

*Promotes detoxification by lowering cholesterol levels, plasma lipid levels, and glucose levels.

*Increases stool water content making it easier to pass.

*Anderson, J., Allgood, L., Lawrence, A., Altringer, L., Jerdeck, G., Hegenhold, D., et al. Cholesterol-lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials 1, 2. American Journal of Clinical Nutrition, 71, 472-479.

*Anderson, J., Allgood, L., Turner, J., Oeltgen, P., & Daggy, B. Effects of psyllium on glucose and serum lipid responses in men with type 2 diabetes and hypercholesterolemia1-3. American Journal of Clinical Nutrition, 70, 466-473.

*Rodriguez-Moran, M., Guerrero-Romero, F., & Lazcano-Burciaga, G. Lipid- and Glucose-Lowering Efficacy of Plantago Psyllium in Type II Diabetes. Journal of Diabetes and its Complications, 12, 273-278.

*Aides in detoxification by aiding in the removal of toxins and preventing the absorption of toxins in the intestines.

*Diminished levels of aflatoxin when added as a dietary supplement.

*Reduces intestinal absorbtion of T-2 toxin.

*Abdel-Wahhab, M., Nadia, S., Farag, I., Abbas, N., & Amra, H. Potential protective effect of HSCAS and bentonite against dietary aflatoxicosis in rat: with special reference to chromosomal aberrations. Natural Toxins, 6, 211-218.

*Carson, M. S., & Smith, T. K. Role of bentonite in prevention of T-2 toxicosis in rats. Journal of Animal Science, 57, 1498-1506.

*Helps to protect against oxidation as tannins are a form of antioxidant

*Contains tannins which have been shown to aid in the control of gastrointestinal parasites through several different methods.

*Aides in removal of wastes by increasing bile excretion.

*Horigome, T., Kumar, R., & Okamoto, K. Effects of condensed tannins prepared from leaves of fodder plants on digestive enzymes in vitro and in the intestine of rats. British Journal of Nutrition, 60, 275-285.

*Koleckar, V., Kubikova, K., Rehakova, Z., Kuca, K., Jun, D., Jahodar, L., et al. Condensed and Hydrolysable Tannins as Antioxidants Influencing the Health. Mini Reviews in Medicinal Chemistry, 8, 436-447.

*Min, B. R., & Hart, S. P. Tannins for suppression of internal parasites. Journal of Animal Science, 81, 102-109.

*Min, B. R., Hart, S. P., Miller, D., Tomita, G. M., Loetz, E., & Sahlu, T. The effect of grazing forage containing condensed tannins on gastro-intestinal parasite infection and milk composition in Angora does. Veterinary Parasitology, 130, 105-113.

*Helps to remove cholesterol from the system which can in turn aide in fat loss.

*Used by many health care practitioners to treat high blood pressure, high cholesterol, and digestive issues.

*In a 3-week study levels of total cholesterol, low-density lipoprotein cholesterol, and apolipoprotien B decreased by 11.3%, 15.3%, and 10.7%.

*Oat bran diets decreased serum cholesterol levels by 19% and low-density lipoprotein cholesterol by 24% and increased fecal bile excretion.

*Increased fecal fat excretion by 47% and fecal bile excretion by 35%.

*Anderson, J., Story, L., Sieling, B., Chen, W. L., Petro, M., & Story, J. Hypocholesterolemic efects of oat-bran or bean intake for hypercholesterolemic men. American Journal of Clinical Nutrition, 40, 1146-1155.

*Judd, P., & Truswell, S. The effect of rolled oats on blood lipids and fecal steroid excretion in man. American Journal of Clinical Nutrition, 34, 2061-2067.

*Zhang, J., Hallmans, G., Andersson, H., Bosaues, I., Aman, P., Tidehag, P., et al. Efect of oat bran on plasma cholesterol and bile acid excretion in nine subjects with ileostomies14. American Journal of Clinical Nutrition, 56, 99-105.

*Commonly used to treat gastrointestinal issues as well as blood vessel and heart disorders.

*Shown that in combination with a low fat diet lowers levels of serum cholesterol.

*In a clinical study reduced the total and low-density lipoprotein cholesterol concentrations.

*Was shown to suppress appetite which can aide in weight

*In a clinical study was shown to improve lipid profile.

*Edlarin, L., el al. Flaxseed Improves Lipid Profile without Altering Biomarkers of Bone Metabolism in Postmenopausal Women. The Journal of Clinical Endocrinology & Metabolism, 87, 1527-1532.

*Demark-Wahnefried, W., et al. Flaxseed Supplementation (Not Dietary Fat Restriction) Reduces Prostate Cancer Proliferation Rates in Men Presurgery. Cancer Epidemiology Biomarkers & Prevention, 17, 3577-3587.

*Ibrugger, S., Kristensrn, M., Mikkelsen, M. S., & Astrup, A. Flaxseed dietary fiber supplements for suppression of appetite and food intake. Appetite, 58, 490-495.

*Patade, A., et al Flaxseed Reduces Total and LDL Cholesterol Concentrations in Native American Postmenopausal Women. Journal Of Women's Health, 17, 355-366.

*Prune melanoidins protect against oxidative stress and endothelial cell death.

*Commonly used to ease constipation and is high in antioxidants.

*A clinical study showed that prunes prevent bone loss.

*Has been shown to slow development of atherosclerosis.

*Attaluri, A., Donahoe, R., Valestin, J., Brown, K., & Rao, S. C. Randomised clinical trial: dried plums (prunes) vs. psyllium for constipation. Alimentary Pharmacology & Therapeutics, 33, 822-828.

*Franklin, M., et al. Dried plum prevents bone loss in a male osteoporosis model via IGF-I and the RANK pathway. Bone, 39, 1331-1342.

*Gallaher, C., & Gallaher, D. Dried plums (prunes) reduce atherosclerosis lesion area in apolipoprotein E-deficient mice. British Journal of Nutrition, 101, 233-239.

*Posadino, A. M., et al. Prune melanoidins protect against oxidative stress and endothelial cell death. Frontiers in Bioscience, 1034-1041.

*Used to ease constipation and bowel diseases when taken orally.

*Has been shown to increase the absorption of vitamins C and E which aids in immune support and fat break down.

*Evidence of support in detoxification of organs in animal study.

*Contains physiologically active substances that are effective anti-inflammatory, immunomodulatory, and wound healing.

*Choi, S., & Chung, M. H. A review on the relationship between aloe vera components and their biologic effects. Seminars in Integrative Medicine, 1, 53-62.

*Sing, R. P., Dhanalakshmi, S., & Rao, A. R. Chemomodulatory action of Aloe vera on the profiles of enzymes associated with carcinogen metabolism and antioxidant status regulation in mice. Phytomedicine, 7, 209-219.

*Vinson, J. A., Kharrat, H. A., & Andreoli, L. Effect of Aloe vera preparations on the human bioavailability of vitamins C and E. Phytomedicine, 12, 760-765.

Form of bacteria used to treat digestive issues, gut issues, helicobacter infections, and other types of infections.

*Clinical study shows that it regulates intestinal pain.

*Secretes an active antibacterial substance which aides in intestinal regulation.

*Inhibits cell attachment and cell invasion by enterovirulent bacteria

*Inhibits the growth of campylobacter pylori.

*Bernet-Camard, M. F., et al. The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Applied and Environmental Microbiology, 63, 2747-2753.

*Bernet, M. F., Brassart, D., Neeser, J. R., & Servin, A. L. Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut, 35, 483-489.

*Bhatia, S. J., et al. Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. Journal of Clinical Microbiology, 27, 2328-2330.

*Coconnier, M. H., Lievin, V., Hemery, E., & Servin, A. L. Antagonistic Activity against Helicobacter Infection In Vitro and In Vivo by the Human Lactobacillus acidophilus Strain LB. Applied andEnvironmental Microbiology, 64, 4573-4580.

*Rousseaux, C., et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nature Medicine, 13, 35-37.

*Commonly used treatment for high cholesterol and gastroesophageal reflux disease.

*In a clinical study reduced plasma cholesterol by 7.6% low-density lipoprotein cholesterol by 10.8% which can aide in fat loss.

*In an animal study insulin resistance and other cardiometabolic risk factors were improved.

*Shown to increase small intestine permeability and reduce fluid loss in patients with diarrhea.

*Influences fibrin network structure which helps to lower cholesterol which can aide in weight loss.

*Cerda, J. J., et al. The effects of grapefruit pectin on patients at risk for coronary heart disease without altering diet or lifestyle. Clinical Cardiology, 11, 589-594.

*Rabbani, G. H., et al. Green Banana and Pectin Improve Small Intestinal Permeability and Reduce Fluid Loss in Bangladeshi Children with Persistent Diarrhea. Digestive Diseases and Sciences, 49, 475-484.

*Sanchez, D., et al. Highly Methoxylated Pectin Improves Insulin Resistance and Other Cardiometabolic Risk Factors in Zucker Fatty Rats. Journal of Agricultural and Food Chemistry, 56, 3574-3581.

*Veldman, F. J., et al. Dietary Pectin Influences Fibrin Network Structure In Hypercholesterolaemic Subjects. Thrombosis Research, 86, 183-196.

*Used for weight loss, constipation, blood sugar control, and reducing cholesterol levels.

*Reduced liver cholesterol and cholesterol absorption in an animal study.

*Beneficially affects total cholesterol, low-density lipoprotein cholesterol, triglycerides, and body weight.

*Improves stool frequency.

*Gallaher, C. M., et al. Cholesterol Reduction by Glucomannan and Chitosan Is Mediated by Changes in Cholesterol Absorption and Bile Acid and Fat Excretion in Rats. The Journal of Nutrition, 130, 2753-2759.

*Sood, N., Baker, W. L., & Coleman, C. I. Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis. American Journal of Clinical Nutrition, 88, 1167-1175.

*Staiano, A., et al. Effect Of The Dietary Fiber Glucomannan On Chronic Constipation In Neurologically Impaired Children*1. The Journal of Pediatrics, 41-45.